| Authors: |
Morris PJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA. Electronic address: patrick.morris@nih.gov., Burke RD; Covance Laboratories, Inc., Madison, WI 53704, USA., Sharma AK; Covance Laboratories, Inc., Madison, WI 53704, USA., Lynch DC; Covance Laboratories, Inc., Madison, WI 53704, USA., Lemke-Boutcher LE; Covance Laboratories, Inc., Greenfield, IN 46140, USA., Mathew S; Division of Pharmacology/Toxicology Neuroscience, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Elayan I; Division of Pharmacology/Toxicology Neuroscience, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Rao DB; Division of Pharmacology/Toxicology Neuroscience, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Gould TD; Departments of Psychiatry, Pharmacology, and Anatomy & Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Veterans Affairs Maryland Health Care System, Baltimore, MD, USA., Zarate CA Jr; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA., Zanos P; Department of Psychiatry, Pharmacology, and Physiology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA., Moaddel R; Biomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA., Thomas CJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA. |
